Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown125%
recruiting125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

NCT04710758
completednot_applicable

Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy

NCT02892643
completednot_applicable

Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer

NCT03007550
unknownphase_3

Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection

NCT02980861

Clinical Trials (4)

Showing 4 of 4 trials
NCT04710758Not Applicable

Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

Recruiting
NCT02892643Not Applicable

Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy

Completed
NCT03007550Not Applicable

Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer

Completed
NCT02980861Phase 3

Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4